Oral Rabies Vaccine Trial; Availability of a Supplemental Environmental Assessment, 33798-33799 [2013-13435]
Download as PDF
33798
Notices
Federal Register
Vol. 78, No. 108
Wednesday, June 5, 2013
This section of the FEDERAL REGISTER
contains documents other than rules or
proposed rules that are applicable to the
public. Notices of hearings and investigations,
committee meetings, agency decisions and
rulings, delegations of authority, filing of
petitions and applications and agency
statements of organization and functions are
examples of documents appearing in this
section.
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2013–0046]
Oral Rabies Vaccine Trial; Availability
of a Supplemental Environmental
Assessment
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice of availability and
request for comments.
AGENCY:
SUMMARY: We are advising the public
that the Animal and Plant Health
Inspection Service has prepared a
supplemental environmental assessment
(EA) relative to an oral rabies
vaccination field trial in New
Hampshire, New York, Ohio, Vermont,
and West Virginia. The supplemental
EA analyzes expanding the field trial for
an experimental oral rabies vaccine for
wildlife to additional areas in New
York. The proposed field trial is
necessary to evaluate whether the
wildlife rabies vaccine will produce
sufficient levels of population immunity
against raccoon rabies. We are making
the supplemental EA available to the
public for review and comment.
DATES: We will consider all comments
that we receive on or before July 5,
2013.
You may submit comments
by either of the following methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov/#!document
Detail;D=APHIS-2013-0046-0001.
• Postal Mail/Commercial Delivery:
Send your comment to Docket No.
APHIS–2013–0046, Regulatory Analysis
and Development, PPD, APHIS, Station
3A–03.8, 4700 River Road, Unit 118,
Riverdale, MD 20737–1238.
The supplemental environmental
assessment and any comments we
receive may be viewed at https://www.
regulations.gov/#!docketDetail;D=
mstockstill on DSK4VPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
APHIS-2013-0046 or in our reading
room, which is located in room 1141 of
the USDA South Building, 14th Street
and Independence Avenue SW.,
Washington, DC. Normal reading room
hours are 8 a.m. to 4:30 p.m., Monday
through Friday, except holidays. To be
sure someone is there to help you,
please call (202) 799–7039 before
coming.
This notice and the supplemental
environmental assessment are also
posted on the APHIS Web site at
https://www.aphis.usda.gov/regulations/
ws/ws_nepa_environmental_
documents.shtml.
FOR FURTHER INFORMATION CONTACT: Mr.
Richard Chipman, Rabies Program
Coordinator, Wildlife Services, APHIS,
59 Chennell Drive, Suite 7, Concord, NH
03301; (603) 223–9623. To obtain copies
of the supplemental environmental
assessment, contact Ms. Beth Kabert,
Staff Wildlife Biologist, Wildlife
Services, 140–C Locust Grove Road,
Pittstown, NJ 08867; (908) 735–5654, fax
(908) 735–0821, email:
beth.e.kabert@aphis.usda.gov.
SUPPLEMENTARY INFORMATION:
Background
The Wildlife Services (WS) program
in the Animal and Plant Health
Inspection Service (APHIS) cooperates
with Federal agencies, State and local
governments, and private individuals to
research and implement the best
methods of managing conflicts between
wildlife and human health and safety,
agriculture, property, and natural
resources. Wildlife-borne diseases that
can affect domestic animals and humans
are among the types of conflicts that
APHIS–WS addresses. Wildlife is the
dominant reservoir of rabies in the
United States.
Currently, APHIS conducts an oral
rabies vaccination (ORV) program to
control the spread of rabies. The ORV
program has utilized a vaccinia-rabies
glycoprotein (V–RG) vaccine. APHIS–
WS’ use of the V–RG vaccine has
resulted in several notable
accomplishments, including the
elimination of canine rabies from
sources in Mexico, the successful
control of gray fox rabies virus variant
in western Texas, and the prevention of
any appreciable spread of raccoon rabies
in the eastern United States. While the
prevention of any appreciable spread of
raccoon rabies in the eastern United
PO 00000
Frm 00001
Fmt 4703
Sfmt 4703
States represents a major
accomplishment in rabies management,
the V–RG vaccine has not been effective
in eliminating raccoon rabies from highrisk spread corridors. This fact
prompted APHIS–WS to evaluate rabies
vaccines capable of producing higher
levels of population immunity against
raccoon rabies to better control the
spread of this disease.
In 2011, APHIS–WS initiated a field
trial to study the immunogenicity and
safety of a promising new wildlife rabies
vaccine, human adenovirus type 5
rabies glycoprotein recombinant vaccine
in portions of West Virginia, including
U.S. Department of Agriculture Forest
Service National Forest System lands.
The vaccine used in this field trial is an
experimental oral rabies vaccine called
ONRAB (produced by Artemis
Technologies Inc., Guelph, Ontario,
Canada).
To further assess the immunogenicity
of ONRAB in raccoons and skunks for
raccoon rabies virus variant, APHIS–WS
determined the need to expand the field
trial into portions of New Hampshire,
New York, Ohio, Vermont, as well as
West Virginia, including National Forest
System lands. On July 9, 2012, we
published in the Federal Register (77
FR 40322–40323, Docket No. APHIS–
2012–0052) a notice 1 in which we
announced the availability, for public
review and comment, of an
environmental assessment (EA) that
examined the potential environmental
impacts associated with the proposed
field trial to test the safety and efficacy
of the ONRAB vaccine in New
Hampshire, New York, Ohio, Vermont,
and West Virginia. We announced the
availability of our final EA and finding
of no significant impact in a notice
published in the Federal Register (see
footnote 1) on August 16, 2012 (77 FR
49409–49410, Docket No. APHIS–2012–
0052). The field trial began in August
2012, taking place within approximately
10,483 square miles in portions of New
Hampshire, New York, Ohio, Vermont,
and West Virginia, including portions of
National Forest System lands, excluding
Wilderness Areas. The field trial is a
collaborative effort among APHIS–WS;
the Centers for Disease Control and
Prevention; the vaccine manufacturer;
1 To view the notice, the comments we received,
the EA, and the followup finding of no significant
impact, go to https://www.regulations.gov/
#!docketDetail;D=APHIS-2012-0052.
E:\FR\FM\05JNN1.SGM
05JNN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices
the appropriate agriculture, health, and
wildlife agencies for the States of New
Hampshire, New York, Ohio, Vermont,
and West Virginia; the Ontario Ministry
of Natural Resources; and the Quebec
Ministry of Natural Resources and
Wildlife.
Given promising immunogenicity
levels documented during the field trial
of the ONRAB vaccine and the need for
further field testing, APHIS is
considering expanding the current field
trial for the ONRAB vaccine to
additional counties in New York. APHIS
has prepared a supplemental EA in
which we analyze expanding the area of
the field trial zone in New York to
include Erie, Franklin, Jefferson, Lewis,
Niagara, St. Lawrence, and Wyoming
Counties. This would add
approximately 14 square miles to the
field trial, increasing the field trial from
approximately 10,483 square miles to
approximately 10,697 square miles. The
supplemental EA analyzes a number of
environmental issues or concerns with
the ONRAB vaccine and activities
associated with the field trial, such as
capture and handling animals for
monitoring and surveillance purposes
with regard to the proposed action.
We are making the supplemental EA
available to the public for review and
comment. We will consider all
comments that we receive on or before
the date listed under the heading DATES
at the beginning of this notice.
The supplemental EA may be viewed
on the Regulations.gov Web site or in
our reading room (see ADDRESSES above
for instructions for accessing
Regulations.gov and information on the
location and hours of the reading room).
In addition, paper copies may be
obtained by calling or writing to the
individual listed under FOR FURTHER
INFORMATION CONTACT.
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provisions
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
Implementing Procedures (7 CFR part
372).
Done in Washington, DC, this 3rd day of
June 2013.
Kevin Shea,
Acting Administrator, Animal and Plant
Health Inspection Service.
[FR Doc. 2013–13435 Filed 6–4–13; 8:45 am]
BILLING CODE 3410–34–P
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2013–0032]
National Poultry Improvement Plan;
General Conference Committee
Meeting
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice of meeting.
AGENCY:
We are giving notice of a
meeting of the General Conference
Committee of the National Poultry
Improvement Plan.
DATES: The General Conference
Committee meeting will be held on June
20, 2013, from 7:30 a.m. to 2 p.m.
ADDRESSES: The meeting will be held at
the Hotel Indigo Athens, 500 College
Avenue, Athens, GA.
FOR FURTHER INFORMATION CONTACT: Dr.
Denise L. Brinson, Acting Senior
Coordinator, National Poultry
Improvement Plan, VS, APHIS, 1506
Klondike Road, Suite 101, Conyers, GA
30094; (770) 922–3496.
SUPPLEMENTARY INFORMATION: The
General Conference Committee (the
Committee) of the National Poultry
Improvement Plan (NPIP), representing
cooperating State agencies and poultry
industry members, serves an essential
function by acting as a liaison between
the poultry industry and the Department
in matters pertaining to poultry health.
The Committee meets to discuss
significant poultry health issues and
makes recommendations to improve the
NPIP program.
Topics for discussion at the upcoming
meeting include:
1. Salmonella update.
2. Salmonella tests for consideration.
3. Pooling of avian influenza samples.
4. Cooperative agreements and funds
for testing.
The meeting will be open to the
public. However, due to time
constraints, the public will not be
allowed to participate in the discussions
during the meeting. Written statements
on meeting topics may be filed with the
Committee before or after the meeting
by sending them to the person listed
under FOR FURTHER INFORMATION
CONTACT. Written statements may also
be filed at the meeting. Please refer to
Docket No. APHIS–2013–0032 when
submitting your statements.
If you require special
accommodations, such as a sign
language interpreter, please call or write
the person listed under FOR FURTHER
INFORMATION CONTACT.
SUMMARY:
PO 00000
Frm 00002
Fmt 4703
Sfmt 4703
33799
This notice of meeting is given
pursuant to section 10 of the Federal
Advisory Committee Act (5 U.S.C. App.
2).
Done in Washington, DC, this 3rd day of
June 2013.
Kevin Shea,
Acting Administrator, Animal and Plant
Health Inspection Service.
[FR Doc. 2013–13436 Filed 6–4–13; 8:45 am]
BILLING CODE 3410–34–P
DEPARTMENT OF AGRICULTURE
Forest Service
Newspapers Used for Publication of
Legal Notices by the Intermountain
Region; Utah, Idaho, Nevada, and
Wyoming
Forest Service, USDA.
Notice.
AGENCY:
ACTION:
SUMMARY: This notice lists the
newspapers that will be used by the
ranger districts, forests and regional
office of the Intermountain Region to
publish legal notices required under 36
CFR 215, 219, and 218. The intended
effect of this action is to inform
interested members of the public which
newspapers the Forest Service will use
to publish notices of proposed actions
and notices of decision. This will
provide the public with constructive
notice of Forest Service proposals and
decisions, provide information on the
procedures to comment, object or
appeal, and establish the date that the
Forest Service will use to determine if
comments or appeals were timely.
DATES: Publication of legal notices in
the listed newspapers will begin on or
after June 2013. The list of newspapers
will remain in effect until October 2013,
when another notice will be published
in the Federal Register.
FOR FURTHER INFORMATION CONTACT: Kris
Rutledge, Regional Appeals
Coordinator, Intermountain Region, 324
25th Street, Ogden, UT 84401, and
phone (801) 625–5146.
SUPPLEMENTARY INFORMATION: The
administrative procedures at 36 CFR
215, 219, and 218 require the Forest
Service to publish notices in a
newspaper of general circulation. The
content of the notices is specified in 36
CFR 215, 219 and 218. In general, the
notices will identify: The decision or
project, by title or subject matter; the
name and title of the official making the
decision; how to obtain additional
information; and where and how to file
comments or appeals. The date the
notice is published will be used to
establish the official date for the
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 78, Number 108 (Wednesday, June 5, 2013)]
[Notices]
[Pages 33798-33799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13435]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 /
Notices
[[Page 33798]]
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
[Docket No. APHIS-2013-0046]
Oral Rabies Vaccine Trial; Availability of a Supplemental
Environmental Assessment
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Notice of availability and request for comments.
-----------------------------------------------------------------------
SUMMARY: We are advising the public that the Animal and Plant Health
Inspection Service has prepared a supplemental environmental assessment
(EA) relative to an oral rabies vaccination field trial in New
Hampshire, New York, Ohio, Vermont, and West Virginia. The supplemental
EA analyzes expanding the field trial for an experimental oral rabies
vaccine for wildlife to additional areas in New York. The proposed
field trial is necessary to evaluate whether the wildlife rabies
vaccine will produce sufficient levels of population immunity against
raccoon rabies. We are making the supplemental EA available to the
public for review and comment.
DATES: We will consider all comments that we receive on or before July
5, 2013.
ADDRESSES: You may submit comments by either of the following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov/#!documentDetail;D=APHIS-2013-0046-0001.
Postal Mail/Commercial Delivery: Send your comment to
Docket No. APHIS-2013-0046, Regulatory Analysis and Development, PPD,
APHIS, Station 3A-03.8, 4700 River Road, Unit 118, Riverdale, MD 20737-
1238.
The supplemental environmental assessment and any comments we
receive may be viewed at https://www.regulations.gov/#!docketDetail;D=APHIS-2013-0046 or in our reading room, which is
located in room 1141 of the USDA South Building, 14th Street and
Independence Avenue SW., Washington, DC. Normal reading room hours are
8 a.m. to 4:30 p.m., Monday through Friday, except holidays. To be sure
someone is there to help you, please call (202) 799-7039 before coming.
This notice and the supplemental environmental assessment are also
posted on the APHIS Web site at https://www.aphis.usda.gov/regulations/ws/ws_nepa_environmental_documents.shtml.
FOR FURTHER INFORMATION CONTACT: Mr. Richard Chipman, Rabies Program
Coordinator, Wildlife Services, APHIS, 59 Chennell Drive, Suite 7,
Concord, NH 03301; (603) 223-9623. To obtain copies of the supplemental
environmental assessment, contact Ms. Beth Kabert, Staff Wildlife
Biologist, Wildlife Services, 140-C Locust Grove Road, Pittstown, NJ
08867; (908) 735-5654, fax (908) 735-0821, email:
beth.e.kabert@aphis.usda.gov.
SUPPLEMENTARY INFORMATION:
Background
The Wildlife Services (WS) program in the Animal and Plant Health
Inspection Service (APHIS) cooperates with Federal agencies, State and
local governments, and private individuals to research and implement
the best methods of managing conflicts between wildlife and human
health and safety, agriculture, property, and natural resources.
Wildlife-borne diseases that can affect domestic animals and humans are
among the types of conflicts that APHIS-WS addresses. Wildlife is the
dominant reservoir of rabies in the United States.
Currently, APHIS conducts an oral rabies vaccination (ORV) program
to control the spread of rabies. The ORV program has utilized a
vaccinia-rabies glycoprotein (V-RG) vaccine. APHIS-WS' use of the V-RG
vaccine has resulted in several notable accomplishments, including the
elimination of canine rabies from sources in Mexico, the successful
control of gray fox rabies virus variant in western Texas, and the
prevention of any appreciable spread of raccoon rabies in the eastern
United States. While the prevention of any appreciable spread of
raccoon rabies in the eastern United States represents a major
accomplishment in rabies management, the V-RG vaccine has not been
effective in eliminating raccoon rabies from high-risk spread
corridors. This fact prompted APHIS-WS to evaluate rabies vaccines
capable of producing higher levels of population immunity against
raccoon rabies to better control the spread of this disease.
In 2011, APHIS-WS initiated a field trial to study the
immunogenicity and safety of a promising new wildlife rabies vaccine,
human adenovirus type 5 rabies glycoprotein recombinant vaccine in
portions of West Virginia, including U.S. Department of Agriculture
Forest Service National Forest System lands. The vaccine used in this
field trial is an experimental oral rabies vaccine called ONRAB
(produced by Artemis Technologies Inc., Guelph, Ontario, Canada).
To further assess the immunogenicity of ONRAB in raccoons and
skunks for raccoon rabies virus variant, APHIS-WS determined the need
to expand the field trial into portions of New Hampshire, New York,
Ohio, Vermont, as well as West Virginia, including National Forest
System lands. On July 9, 2012, we published in the Federal Register (77
FR 40322-40323, Docket No. APHIS-2012-0052) a notice \1\ in which we
announced the availability, for public review and comment, of an
environmental assessment (EA) that examined the potential environmental
impacts associated with the proposed field trial to test the safety and
efficacy of the ONRAB vaccine in New Hampshire, New York, Ohio,
Vermont, and West Virginia. We announced the availability of our final
EA and finding of no significant impact in a notice published in the
Federal Register (see footnote 1) on August 16, 2012 (77 FR 49409-
49410, Docket No. APHIS-2012-0052). The field trial began in August
2012, taking place within approximately 10,483 square miles in portions
of New Hampshire, New York, Ohio, Vermont, and West Virginia, including
portions of National Forest System lands, excluding Wilderness Areas.
The field trial is a collaborative effort among APHIS-WS; the Centers
for Disease Control and Prevention; the vaccine manufacturer;
[[Page 33799]]
the appropriate agriculture, health, and wildlife agencies for the
States of New Hampshire, New York, Ohio, Vermont, and West Virginia;
the Ontario Ministry of Natural Resources; and the Quebec Ministry of
Natural Resources and Wildlife.
---------------------------------------------------------------------------
\1\ To view the notice, the comments we received, the EA, and
the followup finding of no significant impact, go to https://www.regulations.gov/#!docketDetail;D=APHIS-2012-0052.
---------------------------------------------------------------------------
Given promising immunogenicity levels documented during the field
trial of the ONRAB vaccine and the need for further field testing,
APHIS is considering expanding the current field trial for the ONRAB
vaccine to additional counties in New York. APHIS has prepared a
supplemental EA in which we analyze expanding the area of the field
trial zone in New York to include Erie, Franklin, Jefferson, Lewis,
Niagara, St. Lawrence, and Wyoming Counties. This would add
approximately 14 square miles to the field trial, increasing the field
trial from approximately 10,483 square miles to approximately 10,697
square miles. The supplemental EA analyzes a number of environmental
issues or concerns with the ONRAB vaccine and activities associated
with the field trial, such as capture and handling animals for
monitoring and surveillance purposes with regard to the proposed
action.
We are making the supplemental EA available to the public for
review and comment. We will consider all comments that we receive on or
before the date listed under the heading DATES at the beginning of this
notice.
The supplemental EA may be viewed on the Regulations.gov Web site
or in our reading room (see ADDRESSES above for instructions for
accessing Regulations.gov and information on the location and hours of
the reading room). In addition, paper copies may be obtained by calling
or writing to the individual listed under FOR FURTHER INFORMATION
CONTACT.
The EA has been prepared in accordance with: (1) The National
Environmental Policy Act of 1969 (NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on Environmental Quality for
implementing the procedural provisions of NEPA (40 CFR parts 1500-
1508), (3) USDA regulations implementing NEPA (7 CFR part 1b), and (4)
APHIS' NEPA Implementing Procedures (7 CFR part 372).
Done in Washington, DC, this 3rd day of June 2013.
Kevin Shea,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 2013-13435 Filed 6-4-13; 8:45 am]
BILLING CODE 3410-34-P